
Biosearch Technologies is part of LGC Diagnostics & Genomics – Learn More
H-phosphonate monomers are useful for the preparation of internucleotide linkages that are not attainable by phosphoramidite chemistry.(1)
Despite being a niche technique, the advantage of this chemistry over phosphoramidite chemistry is that in one reaction the backbone of the entire oligonucleotide is converted to the required form. This is typically oxidation to give a sugar-phosphate backbone or sulphurised to give a thiophosphate-sugar backbone, or conversion to the silyl phosphite triester which provides a useful means of generating a variety of phosphorus analogues.(2)
The H-phosphonate moiety renders phosphate protection unnecessary and the nucleobases are deprotected using ammonium hydroxide conditions applicable to any unmodified or phosphorothioate oligonucleotide. A popular application of H-phosphonate method is the synthesis of radiolabelled phosphorothioates.(3)
The ancillary reagents required for H-phosphonate chemistry are different from phosphoramidite chemistry,(4) and not available through the NAC portfolio. We recommend anyone using this chemistry prepares the ancillary solutions fresh for use.
Ref:
| LK2005 | dT-H Phosphonate, TEA Salt |
| LK2006 | dG-H Phosphonate, TEA Salt |
| LK2007 | dA-H Phosphonate, TEA Salt |
| LK2035 | dC-H Phosphonate, DBU Salt |
Please note that the liquid reagents used in H-phosphonate synthesis are unfortunately not available from Link Technologies.
Dilution volumes (in ml) are for 0.1M solutions in dry acetonitrile/pyridine (1:1). Adjust accordingly for other concentrations. For µmol pack sizes, products should be diluted as 100µmol/ml to achieve 0.1M, regardless of molecular weight.
Item |
Mol. Formula |
Mol. Wt. |
Unit Wt. |
250mg |
500mg |
1g |
| LK2005 | C37H48N3O9P | 707.79 | 304.20 | 3.52 | 7.04 | 14.09 |
| LK2006 | C41H53N6O9P | 804.89 | 329.21 | 3.11 | 6.21 | 12.42 |
| LK2007 | C44H51N6O8P | 822.90 | 313.21 | 3.04 | 6.08 | 12.15 |
| LK2035 | C43H51N4O9P | 849.93 | 289.18 | 2.94 | 5.88 | 11.77 |
All monomers must be dissolved in acetonitrile/ pyridine (1:1).
Normal deblock is used, however activation is carried out with 1-adamantane carbonyl chloride dissolved in acetonitrile/pyridine (95:5). Capping is carried out with the TEA salt of isopropyl phosphite.
There are two oxidation steps and they need only be carried out at the end of the synthesis. The first is accomplished using 0.1M iodine in pyridine/ N-methylimidazole/water/THF (5:1:5:89), and the second with 0.1M iodine in triethylamine/water/ THF (5:5:90).
Standard oligonucleotide deprotection conditions can be applied when deprotecting an oligo synthesised using these products.
Refrigerate monomers. Stability in solution is approximately 1 week.
Need some support with placing an order, setting up an account, or finding the right protocol?
Contact us| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |